Crossmark

Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?

Crossref DOI link: https://doi.org/10.1186/s40001-023-01038-1

Published Online: 2023-09-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maslub, Mohammed G. http://orcid.org/0000-0003-3041-6595
Radwan, Mahasen A. http://orcid.org/0000-0002-0595-8010
Daud, Nur Aizati Athirah http://orcid.org/0000-0003-4336-9468
Sha’aban, Abubakar http://orcid.org/0000-0002-5491-9851
Funding

Funding for this research was provided by:

The Science, Technology & Innovation Funding Authority
License Information

Text and Data Mining valid from 2023-09-27

Version of Record valid from 2023-09-27
More Information

Article History

Received: 8 November 2022

Accepted: 31 January 2023

First Online: 27 September 2023

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below